v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 2,646,556 $ 14 $ 3,234,860 $ (292) $ (588,026)
Beginning balance (in shares) at Dec. 31, 2022   140,027      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock pursuant to equity incentive plans 891   891    
Issuance of common stock pursuant to equity incentive plans (in shares)   758      
Stock-based compensation expense 96,472   96,472    
Foreign currency translation adjustment 327     327  
Net Loss (193,604)       (193,604)
Ending balance at Mar. 31, 2023 2,550,642 $ 14 3,332,223 35 (781,630)
Ending balance (in shares) at Mar. 31, 2023   140,785      
Beginning balance at Dec. 31, 2023 2,326,333 $ 14 3,623,747 159 (1,297,587)
Beginning balance (in shares) at Dec. 31, 2023   143,502      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock pursuant to equity incentive plans 8,262   8,262    
Issuance of common stock pursuant to equity incentive plans (in shares)   1,013      
Stock-based compensation expense 94,632   94,632    
Shares withheld for taxes related to net share settlement of equity awards (in shares)   (350)      
Shares withheld for taxes related to net share settlement of equity awards (22,206)   (22,206)    
Foreign currency translation adjustment (337)     (337)  
Net Loss (50,855)       (50,855)
Ending balance at Mar. 31, 2024 $ 2,355,829 $ 14 $ 3,704,435 $ (178) $ (1,348,442)
Ending balance (in shares) at Mar. 31, 2024   144,165